Goldman Sachs
STJ

Goldman Sachs’s St Jude Medical STJ Stock Holding History

Goldman Sachs’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-147,600
Closed -$11.8M – 7267
2016
Q4 		$11.8M Buy
147,600
+54,700
+59% +$4.34M ﹤0.01% 2330
2016
Q3 		$7.41M Buy
92,900
+91,000
+4,789% +$7.35M ﹤0.01% 2699
2016
Q2 		$148K Sell
1,900
-900
-32% -$64.2K ﹤0.01% 5905
2016
Q1 		$154K Sell
2,800
-38,700
-93% -$2.11M ﹤0.01% 5812
2015
Q4 		$2.56M Sell
41,500
-12,700
-23% -$801K ﹤0.01% 3423
2015
Q3 		$3.42M Buy
54,200
+4,000
+8% +$285K ﹤0.01% 3244
2015
Q2 		$3.67M Sell
50,200
-99,700
-67% -$7.2M ﹤0.01% 3229
2015
Q1 		$9.8M Sell
149,900
-9,800
-6% -$652K ﹤0.01% 2311
2014
Q4 		$10.4M Buy
159,700
+112,800
+241% +$7.26M ﹤0.01% 2316
2014
Q3 		$2.82M Sell
46,900
-148,300
-76% -$9.69M ﹤0.01% 3587
2014
Q2 		$13.5M Buy
195,200
+133,300
+215% +$8.64M ﹤0.01% 2114
2014
Q1 		$4.05M Sell
61,900
-117,200
-65% -$7.63M ﹤0.01% 3261
2013
Q4 		$11.1M Buy
179,100
+2,500
+1% +$145K ﹤0.01% 2278
2013
Q3 		$9.47M Sell
176,600
-60,000
-25% -$3.09M ﹤0.01% 2312
2013
Q2 		$10.8M Buy
+236,600
New +$10.3M ﹤0.01% 2015

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Goldman Sachs's STJ Position: Q1 2017 in Review

Goldman Sachs sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,601,287 shares — an estimated $690M sold.

Goldman Sachs first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $690M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Goldman Sachs reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Goldman Sachs sold 8,601,287 St Jude Medical shares in Q1 2017, an estimated $690M.
  • Goldman Sachs first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Goldman Sachs's St Jude Medical position peaked at $690M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.